Baxter Issues Voluntary Nationwide Recall of One Lot of Heparin Sodium . . . Baxter International Inc (NYSE:BAX) is voluntarily recalling one lot of Heparin Sodium in 0 9% Sodium Chloride Injection to the consumer level due to the potential for elevated endotoxin levels based on issues related to the bacterial endotoxin test specific to lot number N008235
Drug Shortage Detail: Heparin Injection - ASHP Pfizer has heparin injection on shortage due to increased demand and manufacturing delays Pfizer has temporarily discontinued heparin 1,000 unit mL 10 mL vials, 1,000 unit mL 30 mL vials, 5,000 unit mL 1 mL vials, and 5,000 unit mL 10 mL vials Sagent did not provide a reason for the shortage Sky discontinued heparin injection
Heparin Induced Thrombocytopaenia • LITFL • CCC Haematology Heparin Induced Thrombocytopaenia Syndrome (HITS) Heparin Induced Thrombosis with Thrombocytopaenia Syndrome (HITTS) PATHOPHYSIOLOGY Platelet Factor 4 PF4 is released on platelet activation -> binds anionic glycosaminoglycans on cell surfaces -> inhibit the formation of megakaryocytes and angiogenesis + modulate immune response
Baxter International Recalls Heparin Injection Due to Safety Concerns The implicated lot was distributed to healthcare facilities, wholesalers, and distributors across the United States from March 12, 2023, to August 24, 2023 Baxter has cited issues with the bacterial endotoxin test related to this specific lot as the reason for the elevated levels
Baxter Heparin Sodium Recall - pharmacy. ca. gov Baxter is recalling one lot of Heparin Sodium in 0 9% Sodium Chloride Injection due to the potential for elevated endotoxin levels based on issues related to the bacterial endotoxin test specific to lot number N008235
FDA Warns - Single Lot Of Heparin Sodium In 0. 9% Sodium . . . - TruLaw According to the FDA, Baxter International Inc , of Deerfield, Illinois, has recalled lot number N008235 of its Heparin Sodium in 0 9% Sodium Chloride Injection after issues with a bacterial endotoxin test revealed a potential for elevated endotoxin levels in the batch
Baxter Issues Voluntary Nationwide Recall of One Lot of Heparin Sodium . . . Use of heparin with higher than acceptable endotoxin levels may lead to significant adverse health consequences ranging from febrile reactions to toxic shock, multi-organ failure and death To date, Baxter has not received any reports of adverse events related to this issue